Inovio Pharmaceuticals (INO) Competitors

$12.00
-0.79 (-6.18%)
(As of 05/17/2024 ET)

INO vs. SGHT, TLSI, ANGO, UTMD, NPCE, RCEL, TMCI, GUTS, TCMD, and PROF

Should you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), AngioDynamics (ANGO), Utah Medical Products (UTMD), NeuroPace (NPCE), AVITA Medical (RCEL), Treace Medical Concepts (TMCI), Fractyl Health (GUTS), Tactile Systems Technology (TCMD), and Profound Medical (PROF). These companies are all part of the "surgical & medical instruments" industry.

Inovio Pharmaceuticals vs.

Sight Sciences (NASDAQ:SGHT) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends.

Sight Sciences has a beta of 2.73, indicating that its stock price is 173% more volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Sight Sciences has a net margin of -67.18% compared to Sight Sciences' net margin of -16,238.91%. Inovio Pharmaceuticals' return on equity of -44.45% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-67.18% -44.45% -32.01%
Inovio Pharmaceuticals -16,238.91%-88.13%-63.03%

In the previous week, Inovio Pharmaceuticals had 30 more articles in the media than Sight Sciences. MarketBeat recorded 30 mentions for Inovio Pharmaceuticals and 0 mentions for Sight Sciences. Inovio Pharmaceuticals' average media sentiment score of 1.89 beat Sight Sciences' score of 0.27 indicating that Sight Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Sight Sciences Very Positive
Inovio Pharmaceuticals Neutral

Sight Sciences has higher revenue and earnings than Inovio Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$81.06M3.28-$55.55M-$1.12-4.77
Inovio Pharmaceuticals$717.07K433.62-$135.12MN/AN/A

Inovio Pharmaceuticals received 702 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 71.49% of users gave Inovio Pharmaceuticals an outperform vote while only 31.91% of users gave Sight Sciences an outperform vote.

CompanyUnderperformOutperform
Sight SciencesOutperform Votes
15
31.91%
Underperform Votes
32
68.09%
Inovio PharmaceuticalsOutperform Votes
717
71.49%
Underperform Votes
286
28.51%

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. 27.1% of Sight Sciences shares are held by company insiders. Comparatively, 2.5% of Inovio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sight Sciences presently has a consensus price target of $4.70, suggesting a potential downside of 11.99%. Inovio Pharmaceuticals has a consensus price target of $70.67, suggesting a potential upside of 488.89%. Given Sight Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inovio Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

Sight Sciences beats Inovio Pharmaceuticals on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INO vs. The Competition

MetricInovio PharmaceuticalsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$310.93M$3.98B$5.16B$7.96B
Dividend YieldN/A1.97%43.85%3.91%
P/E RatioN/A9.68125.8015.24
Price / Sales433.6271.122,367.6177.84
Price / CashN/A47.7536.3731.98
Price / Book3.305.285.744.76
Net Income-$135.12M$4.90M$105.71M$217.17M
7 Day Performance12.68%1.96%1.39%2.90%
1 Month Performance17.65%3.25%4.27%6.57%
1 Year Performance-87.22%18.91%7.71%10.17%

Inovio Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGHT
Sight Sciences
0.3916 of 5 stars
$5.45
+0.6%
$4.70
-13.8%
-44.7%$271.19M$81.06M-4.87214Positive News
TLSI
TriSalus Life Sciences
3.1636 of 5 stars
$10.15
-0.9%
$16.00
+57.6%
N/A$271.61M$18.51M0.00106News Coverage
ANGO
AngioDynamics
4.0481 of 5 stars
$6.17
+0.8%
$14.25
+131.0%
-36.8%$247.17M$338.75M-1.27815Positive News
UTMD
Utah Medical Products
3.0127 of 5 stars
$68.48
+0.0%
N/A-26.0%$245.78M$49.04M15.22169
NPCE
NeuroPace
3.4952 of 5 stars
$8.51
-0.1%
$15.67
+84.1%
+90.0%$244.83M$65.42M-7.15171
RCEL
AVITA Medical
0.9176 of 5 stars
$8.72
+4.4%
$27.80
+218.8%
-32.2%$224.98M$50.14M-6.23207Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Gap Down
High Trading Volume
TMCI
Treace Medical Concepts
3.574 of 5 stars
N/A$13.57
+∞
-80.7%$310.05M$187.12M0.00516Analyst Downgrade
Insider Buying
News Coverage
Gap Up
High Trading Volume
GUTS
Fractyl Health
0 of 5 stars
$6.62
+8.5%
$22.00
+232.3%
N/A$316.95M$120,000.000.00102Gap Up
TCMD
Tactile Systems Technology
3.4016 of 5 stars
$13.63
-1.4%
$30.00
+120.1%
-33.3%$323.88M$276.67M11.36992Analyst Downgrade
PROF
Profound Medical
2.1827 of 5 stars
$8.21
+7.3%
$14.58
+77.6%
-38.9%$200.57M$7.20M-6.36131Gap Up

Related Companies and Tools

This page (NASDAQ:INO) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners